...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>AIDS care. >The impact of taking or not taking ARVs on HIV stigma as reported by persons living with HIV infection in five African countries.
【24h】

The impact of taking or not taking ARVs on HIV stigma as reported by persons living with HIV infection in five African countries.

机译：据五个非洲国家的艾滋病毒感染者报告，服用或不服用抗逆转录病毒药物对艾滋病毒耻辱的影响。

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

AIM: This study examined the impact of taking or not taking antiretroviral (ARV) medications on stigma, as reported by people living with HIV infection in five African countries. DESIGN: A two group (taking or not taking ARVs) by three (time) repeated measures analysis of variance examined change in reported stigma in a cohort sample of 1454 persons living with HIV infection in Lesotho, Malawi, South Africa, Swaziland, and Tanzania. Participants self-reported taking ARV medications and completed a standardized stigma scale validated in the African context. Data were collected at three points in time, from January 2006 to March 2007. Participants taking ARV medications self-reported a mean CD4 count of 273 and those not taking ARVs self-reported a mean CD4 count of 418. RESULTS: Both groups reported significant decreases in total HIV stigma over time; however, people taking ARVs reported significantly higher stigma at Time 3 compared to those not taking ARVs. DISCUSSION: This study documents that this sample of 1454 HIV infected persons in five countries in Africa reported significantly less HIV stigma over time. In addition, those participants taking ARV medications experienced significantly higher HIV stigma over time compared to those not taking ARVs. This finding contradicts some authors' opinions that when clients enroll in ARV medication treatment it signifies that they are experiencing less stigma. This work provides caution to health care providers to alert clients new to ARV treatment that they may experience more stigma from their families and communities when they learn they are taking ARV medications.
机译：目的：这项研究检查了服用或不服用抗逆转录病毒（ARV）药物对耻辱的影响，据五个非洲国家的HIV感染者报告。设计：在莱索托，马拉维，南非，斯威士兰和坦桑尼亚的一组1454名HIV感染者的队列样本中，一组两组（采用或不采用抗逆转录病毒药物）通过三（重复）次方差分析检查了报告的柱头的变化。 。参与者自我报告服用了抗逆转录病毒药物并完成了在非洲范围内验证的标准化柱头量表。从2006年1月至2007年3月的三个时间点收集了数据。服用ARV药物的参与者自我报告的平均CD4计数为273，未服用ARV药物的参与者自我报告的平均CD4计数为418。结果：两组均报告了显着性随着时间的流逝，艾滋病毒总污名的减少;但是，与不服用抗逆转录病毒药物的人相比，服用抗逆转录病毒药物的人在时间3的耻辱感明显更高。讨论：这项研究表明，在非洲五个国家的1454名HIV感染者的样本中，随着时间的推移，艾滋病毒的污名明显减少。此外，与不服用抗逆转录病毒药物的参与者相比，服用抗逆转录病毒药物的参与者随着时间的流逝，艾滋病毒的耻辱感明显更高。这一发现与一些作者的观点相矛盾，即当客户参加抗逆转录病毒药物治疗时，表明他们遭受的耻辱减少了。这项工作为医疗保健提供者提供了警告，以提醒刚接受ARV治疗的客户在得知他们正在服用ARV药物时可能会遭受来自家人和社区的更多污名。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号